The Effect Of Medical Nutritional Therapy On Patients With Sarcopenic Obesity Receiving Peritoneal Dialysis Treatment

Sarcopenic Obesity Clinical Trial

Official title:

The Effect of Medical Nutrition Therapy on Anthropometric Measurements and Blood Parameters in Sarcopenic Obesity Patients Receiving Peritoneal Dialysis Treatment

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05797181
• Other study ID #: ABDemirbasPD
• Status: Completed
• Phase: N/A
• Start date: February 7, 2023
• Est. completion date: May 15, 2023

Study information

• Verified date: January 2024
• Source: Atlas University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In this study, it was aimed to evaluate the effectiveness of medical nutrition therapy to be applied to patients with sarcopenic obesity receiving peritoneal dialysis treatment by measuring anthropometric measurements and blood parameters.

Description:

Efficacy of medical nutrition therapy in patients with saecopenic obesity receiving peritoneal dialysis treatment, general information form after patients filled in the voluntary consent form, SARC-F questionnaire as sarcopenia screening test, International Physical Activity Questionnaire (IPAQ), muscle mass, muscle strength, physical performance, BIA measurement, anthropometric measurements, laboratory findings and three-day food consumption records will be evaluated.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 15
• Est. completion date: May 15, 2023
• Est. primary completion date: May 8, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• Volunteering to participate in research

• Be between the ages of 18-70

• To receive peritoneal dialysis treatment and to come to the hospital regularly once a month for treatment

Exclusion Criteria:

• Presence of any other disease that causes muscle wasting

• Patients using any supplement or enteral product in their diet

Related Conditions & MeSH terms

• Obesity
• Peritoneal Dialysis Complication
• Sarcopenic Obesity

Intervention

Other:
• medical nutrition therapy in kidney diseases
Planning and implementation of diets containing high protein, low potassium, low phosphorus, personalized adjusted carbohydrates

Locations

Country	Name	City	State
Turkey	Marmara University	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Atlas University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in muscle strength	Handgrip strength (kg) will be measured by using the CAMRY EH101 dynamometer. Hand grip strength <16 kg for women and <27 kg for men indicates low muscle strength.	Baseline to 3 months after diet programme
Primary	Change in the skeletal muscle mass	Skeletal muscle mass (kg) will be measured by using bioelectrical impedance analysis.	Baseline to 3 months after diet programme
Primary	Change in the physical performance	4-meter walking speed test will be performed. A walking speed of =0.8 m/sec is considered as an indicator of severe sarcopenia.	Baseline to 3 months after diet programme
Primary	Change of the fat mass	Fat mass (kg) will be measured by using bioelectrical impedance analysis.	Baseline to 3 months after diet programme
Primary	Changes of percentage of body fat	Percentage of body fat will be measured by using bioelectrical impedance analysis.	Baseline to 3 months after diet programme
Primary	Changes of body mass index	The weight and height will be combined to report BMI in kg/m2.	Baseline to 3 months after diet programme